Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma.
@article{Wang2008UseOS, title={Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma.}, author={Meng-Ting Wang and Grant H Skrepnek and Edward Armstrong and Duane L. Sherrill and Robin B. Harris and Cheng-Liang Tsai and Daniel C. Malone}, journal={Current medical research and opinion}, year={2008}, volume={24 3}, pages={ 859-67 } }
RATIONALE
Studies evaluating the safety of salmeterol are inconclusive, which might be the result from not taking into account the impact of concomitant inhaled corticosteroids (ICS).
OBJECTIVE
To study whether salmeterol use with and without concomitant ICS, respectively, was associated with an increased risk of asthma-related hospitalizations among patients with asthma.
METHODS
A case-control study nested within a cohort of patients with asthma, identified in the year 2000, over a 2-year… CONTINUE READING
Topics from this paper.
Citations
Publications citing this paper.
SHOWING 1-4 OF 4 CITATIONS
Salmeterol/Fluticasone Propionate
VIEW 12 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED